Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Iambic Therapeutics (IAM)

$14.41 +$0.15 (+1.05%)

Day’s range
$14.00–$15.25
Volume
148,953

IAM price history

IAM closed at $14.41 on Oct. 26, 2026. Over the past year, its daily close ranged from $14.26 on Oct. 23, 2026 to $23.81 on Oct. 16, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $13 to $25, not from zero.
Data table: IAM daily closes, the past year
IAM daily closing prices, Oct. 15, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$14.41
Oct. 23, 2026$14.26
Oct. 22, 2026$14.67
Oct. 21, 2026$15.80
Oct. 20, 2026$16.01
Oct. 19, 2026$16.34
Oct. 16, 2026$23.81
Oct. 15, 2026$18.91

Key figures

Average daily volume
1.3MPast 3 months
Market value
$683.0M
Dividend yield
—

What Wall Street says about IAM

No Wall Street firm has published a rating or price-target change on IAM in the past 90 days.

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Iambic Therapeutics, Inc. Common Stock

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Listed
Oct. 15, 2026

iambic.ai, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about IAM is on the site yet.